Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m641 · Cited by 727

Chinese society of cardiology expert consensus statement on the diagnosis and treatment of adult fulminant myocarditis

Section of Precision Medicine Group of Chinese Society of Cardiology, Wang, D. W., Editorial Board of Chinese Journal of Cardiology, Working Group of Adult Fulminant Myocarditis, Li, S., Jiang, J., Yan, J., Zhao, C., Wang, Y., Ye-xin, M., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-018-9385-3 · Cited by 128

Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2

Körner, R. W., Majjouti, M., Alcazar, M. A. A., & Mahabir, E. (2020) · Viruses · doi:10.3390/v12080880 · Cited by 184

Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective

Boukhris, M., Hillani, A., Moroni, F., Annabi, M., Addad, F., Ribeiro, M. H., Mansour, S., Zhao, X., Ybarra, L. F., Abbate, A., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.05.018 · Cited by 178

Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)

Carter, B., Collins, J., Barlow-Pay, F., Rickard, F., Bruce, E., Verduri, A., Quinn, T. J., Mitchell, E., Price, A., Vilches‐Moraga, A., et al. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.07.013 · Cited by 171

Current State of Evidence: Influence of Nutritional and Nutrigenetic Factors on Immunity in the COVID-19 Pandemic Framework

Galmés, S., Serra, F. A., & Palou, A. (2020) · Nutrients · doi:10.3390/nu12092738 · Cited by 179

Azithromycin in viral infections

Oliver, M., & Hinks, T. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2163 · Cited by 181

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19

Johnson, K. D., Harris, C. C., Cain, J., Hummer, C., Goyal, H., & Perisetti, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00526 · Cited by 185

Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome

Sukocheva, O. A., Maksoud, R., Beeraka, N. M., Madhunapantula, S. V., Sinelnikov, M. Y., Nikolenko, V. N., Неганова, М. Е., Klochkov, S. G., Kamal, M. A., Staines, D., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.11.013 · Cited by 182

Tocilizumab for treatment of patients with severe COVID–19: A retrospective cohort study

Kewan, T. Z., Covut, F., Al‐Jaghbeer, M. J., Rose, L., Gopalakrishna, K. V., & Akbik, B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100418 · Cited by 176

Is pregnancy a risk factor of COVID-19?

Phoswa, W. N., & Khaliq, O. P. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.06.058 · Cited by 173

A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis

Lu, L., Zhong, W., Bian, Z., Li, Z., Zhang, K., Liang, B., Zhong, Y., Hu, M., Lin, L., Liu, J., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.07.002 · Cited by 171

Secondary Bacterial Infections in Patients With Viral Pneumonia

Manohar, P., Loh, B., Nachimuthu, R., Hua, X., Welburn, S. C., & Leptihn, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00420 · Cited by 173

Cardiovascular diseases burden in COVID-19: Systematic review and meta-analysis

Hessami, A., Shamshirian, A., Heydari, K., Pourali, F., Alizadeh‐Navaei, R., Moosazadeh, M., Abrotan, S., Shojaie, L., Sedighi, S., Shamshirian, D., et al. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.10.022 · Cited by 189

Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study

Cavalli, G., Larcher, A., Tomelleri, A., Campochiaro, C., Della‐Torre, E., Luca, G. D. D., Farina, N., Boffini, N., Ruggeri, A., Poli, A., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00012-6 · Cited by 178

Potential therapeutic use of ebselen for COVID-19 and other respiratory viral infections

Sies, H., & Parnham, M. J. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.06.032 · Cited by 175

Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis

Chidambaram, V., Tun, N. L., Haque, W. Z., Majella, M. G., Sivakumar, R. K., Kumar, A., Hsu, A. T., Ishak, I. A., Nur, A. A., Ayeh, S. K., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241541 · Cited by 176

Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work

Messina, G., Polito, R., Monda, V., Cipolloni, L., Nunno, N. R. D., Mizio, G. D., Murabito, P., Carotenuto, M., Messina, A., Pisanelli, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093104 · Cited by 170

Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran

Salehi, M., Ahmadikia, K., Badali, H., & Khodavaisy, S. (2020) · Mycopathologia · doi:10.1007/s11046-020-00472-7 · Cited by 171

Modeling the viral dynamics of SARS-CoV-2 infection

Wang, S., Pan, Y., Wang, Q., Miao, H., Brown, A. N., & Rong, L. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108438 · Cited by 173

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19

Hoiland, R. L., Fergusson, N. A., Mitra, A. R., Griesdale, D. E. G., Devine, D. V., Stukas, S. K., Cooper, J. G., Thiara, S., Foster, D., Chen, L. Y. C., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002623 · Cited by 172

Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies

Lopes‐Pacheco, M., Silva, P. L., Cruz, F. F., Battaglini, D., Robba, C., Pelosi, P. P., Morales, M. M., Neves, C. C., & Rocco, P. R. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.593223 · Cited by 178

ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up

The Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent, C., Windecker, S., Andreini, D., Arbelo, E., Barbato, E., Bartorelli, A. L., Baumbach, A., Behr, E. R., Berti, S. L., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab697 · Cited by 177

Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis

Farsalinos, K. E., Barbouni, A., Poulas, K. A., Polosa, R., Caponnetto, P., & NIAURA, R. S. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320935765 · Cited by 178

Pre-existing traits associated with Covid-19 illness severity

Ebinger, J. E., Achamallah, N., Ji, H., Claggett, B. L., Sun, N., Botting, P. G., Nguyen, T., Luong, E., Kim, E. H., Park, E. Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236240 · Cited by 174

COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis

Nasiri, M. J., Haddadi, S., Tahvildari, A., Farsi, Y., Arbabi, M., Hasanzadeh, S., Jamshidi, P. K., Murthi, M., & Mirsaeidi, M. S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00459 · Cited by 170

Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients

Daniels, L. B., Sitapati, A. M., Zhang, J., Zou, J., Bui, Q. M., Ren, J., Longhurst, C., Criqui, M. H., & Messer, K. S. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.09.012 · Cited by 171

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Gerotziafas, G., Catalano, M., Colgan, M. P., Pécsvárady, Z., Wautrecht, J. C., Fazeli, B., Olinic, D.-M., Farkas, K., Elalamy, I., Falanga, A., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1715798 · Cited by 171

A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)

Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A. R., & Noubiap, J. J. (2020) · Biomarker Research · doi:10.1186/s40364-020-00217-0 · Cited by 168

Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study

Wang, G., Zhang, Q., Zhao, X., Dong, H., Wu, C., Wu, F., Yu, B., Lv, J., Zhang, S., Wu, G., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01382-9 · Cited by 172

Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients

Alizadehsani, R., Sani, Z. A., Behjati, M., Roshanzamir, Z., Hussain, S., Abedini, N., Hasanzadeh, F., Khosravi, A., Shoeibi, A., Roshanzamir, M., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26699 · Cited by 175

SARS-CoV-2 infection, COVID-19 pathogenesis, and exposure to air pollution: What is the connection?

Woodby, B., Arnold, M. M., & Valacchi, G. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14512 · Cited by 160

Immunomodulation in COVID-19

Ingraham, N. E., Lotfi‐Emran, S., Thielen, B. K., Techar, K., Morris, R., Holtan, S. G., Dudley, R. A., & Tignanelli, C. J. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30226-5 · Cited by 166

COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review

Kowalewski, M., Fina, D., Słomka, A., Raffa, G. M., Martucci, G., Coco, V. L., Piero, M. E. D., Ranucci, M., Suwalski, P., & Lorusso, R. (2020) · Critical Care · doi:10.1186/s13054-020-02925-3 · Cited by 165

COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart

Bois, M. C., Boire, N. A., Layman, A. J., Aubry, M.-C., Alexander, M. P., Roden, A. C., Hagen, C. E., Quinton, R. A., Larsen, C. P., Erben, Y., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050754 · Cited by 163

Influenza infection, SARS, MERS and COVID-19: Cytokine storm – The common denominator and the lessons to be learned

Ryabkova, V. A., Churilov, L. P., & Shoenfeld, Y. (2021) · Clinical Immunology · doi:10.1016/j.clim.2020.108652 · Cited by 164

Chest X-ray severity index as a predictor of in-hospital mortality in coronavirus disease 2019: A study of 302 patients from Italy

Borghesi, A., Zigliani, A., Golemi, S., Carapella, N., Maculotti, P., Farina, D., & Maroldi, R. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.021 · Cited by 163

Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis

Soraya, G. V., & Ulhaq, Z. S. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2020.05.017 · Cited by 163

COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches

Moccia, F. D., Gerbino, A., Lionetti, V., Miragoli, M., Munaron, L., Pagliaro, P., Pasqua, T., Penna, C. R. R., Rocca, C., Samaja, M., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00198-w · Cited by 165

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Gawalko, M. M., Kapłon‐Cieślicka, A., Hohl, M., Dobrev, D., & Linz, D. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100631 · Cited by 162

Autopsy Findings in 32 Patients with COVID-19: A Single-Institution Experience

Elsoukkary, S. S., Mostyka, M., Dillard, A., Berman, D. R., Ma, L. X., Chadburn, A., Yantiss, R. K., Jessurun, J., Seshan, S. V., Borczuk, A., et al. (2020) · Pathobiology · doi:10.1159/000511325 · Cited by 164

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration

Chen, R., Lan, Z., Ye, J., Pang, L., Liu, Y., Wu, W., Qin, X., Guo, Y., & Zhang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.589095 · Cited by 165

Coronavirus-induced myocarditis: A meta-summary of cases

Ho, J. S. Y., Sia, C., Chan, M. Y., Lin, W., & Wong, R. C.-C. (2020) · Heart & Lung · doi:10.1016/j.hrtlng.2020.08.013 · Cited by 161

COVID-19 and the Cardiovascular System

Veer, M., Kumar, A. M., & Ivanova, V. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000323 · Cited by 164

Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients

Jacobs, J. P., Stammers, A. H., Louis, J. S., Hayanga, J. W. A., Firstenberg, M. S., Mongero, L. B., Tesdahl, E. A., Rajagopal, K., Cheema, F. H., Coley, T., et al. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001185 · Cited by 158

The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation

Bösmüller, H. C., Traxler, S., Bitzer, M., Haeberle, H. A., Raiser, W., Nann, D., Frauenfeld, L., Vogelsberg, A., Klingel, K., & Fend, F. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02881-x · Cited by 161

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression

Beltrán-García, J., Osca-Verdegal, R., Pallardó, F. V., Ferreres, J., Rodríguez, M. D. P., Mulet, S., Sanchis‐Gomar, F., Carbonell, N., & García‐Giménez, J. L. (2020) · Antioxidants · doi:10.3390/antiox9100936 · Cited by 162

Cardiac Involvement of COVID-19: A Comprehensive Review

Chang, W., Toh, H. S., Liao, C., & Yu, W. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.10.002 · Cited by 165

Gut-lung axis and dysbiosis in COVID-19

Aktaş, B., & Aslım, B. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-102 · Cited by 170

Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients

Yao, Q., Wang, P., Wang, X., Qie, G., Meng, M., Tong, X., Bai, X., Ding, M., Liu, W., Keke, L., et al. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15312 · Cited by 152

COVID 19: a clue from innate immunity

Birra, D., Benucci, M., Landolfi, L., Merchionda, A., Loi, G., Amato, P., Licata, G., Quartuccio, L., Triggiani, M., & Moscato, P. (2020) · Immunologic Research · doi:10.1007/s12026-020-09137-5 · Cited by 155

Novel Use of Home Pulse Oximetry Monitoring in COVID‐19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization

Shah, S., Majmudar, K., Stein, A., Gupta, N., Suppes, S., Karamanis, M., Capannari, J., Sethi, S., & Patte, C. (2020) · Academic Emergency Medicine · doi:10.1111/acem.14053 · Cited by 152

Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19

Ramarao, P., Joshi, G., & Jagadeesh, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109721 · Cited by 160

Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19

Kumar, R., Rathi, H., Haq, A., Wimalawansa, S. J., & Sharma, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198235 · Cited by 155

Cardiac manifestations in COVID‐19 patients—A systematic review

Shafì, A. M. A., Shaikh, S. A., Shirke, M., Iddawela, S., & Harky, A. (2020) · Journal of Cardiac Surgery · doi:10.1111/jocs.14808 · Cited by 153

Immune responses during COVID-19 infection

Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 167

Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies

Goh, K. J., Wong, J., Tien, C., Ng, S. Y., Wen, S. D., Phua, G. C., & Leong, C. K. (2020) · Critical Care · doi:10.1186/s13054-020-02916-4 · Cited by 163

Anti-inflammatory therapy for COVID-19 infection: the case for colchicine

Reyes, A. Z., Hu, K. A., Teperman, J., Muskardin, T. W., Tardif, J., Shah, B., & Pillinger, M. H. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219174 · Cited by 161

Viruses, periodontitis, and comorbidities

Teles, F., Collman, R. G., Mominkhan, D., & Wang, Y. (2022) · Periodontology 2000 · doi:10.1111/prd.12435 · Cited by 153

C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection

Sahu, B. R., Kampa, R. K., Padhi, A., & Panda, A. K. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.013 · Cited by 152

Point-of-Care Biosensor-Based Diagnosis of COVID-19 Holds Promise to Combat Current and Future Pandemics

Parihar, A., Ranjan, P., Sanghi, S. K., Srivastava, A. K., & Khan, R. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01083 · Cited by 153

Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)

Cenko, E., Badimón, L., Bugiardini, R., Claeys, M. J., Luca, G. D., de Wit, C., Dérumeaux, G., Dorobanţu, M., Duncker, D. J., Eringa, E. C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab298 · Cited by 152

Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis

Li, X., Guan, B., Su, T., Liu, W., Chen, M., Waleed, K. B., Guan, X., Tse, G., & Zhu, Z. (2020) · Heart · doi:10.1136/heartjnl-2020-317062 · Cited by 155

Cardiovascular complications of COVID-19

Farshidfar, F., Koleini, N., & Ardehali, H. (2021) · JCI Insight · doi:10.1172/jci.insight.148980 · Cited by 160

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations

Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801522 · Cited by 154

Liver injury is associated with severe coronavirus disease 2019 (COVID‐19) infection: A systematic review and meta‐analysis of retrospective studies

Parohan, M., Yaghoubi, S., & Seraj, A. (2020) · Hepatology Research · doi:10.1111/hepr.13510 · Cited by 157

COVID-19 Pandemic: Cardiovascular Complications and Future Implications

Bandyopadhyay, D., Akhtar, T., Hajra, A., Gupta, M., Das, A., Chakraborty, S., Pal, I., Patel, N., Amgai, B., Ghosh, R. K., et al. (2020) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-020-00420-2 · Cited by 149

The SARS-CoV-2 and mental health: From biological mechanisms to social consequences

Szcześniak, D. M., Gładka, A., Misiak, B., Cyran, A., & Rymaszewska, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110046 · Cited by 157

C-reactive protein: structure, function, regulation, and role in clinical diseases

Zhou, H.-H., Tang, Y.-L., Xu, T.-H., & Cheng, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425168 · Cited by 162

Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19

Perrin, P., Collongues, N., Baloglu, S., Bedo, D., Bassand, X., Lavaux, T., Gautier-Vargas, G., Keller, N., Kremer, S., Fafi‐Kremer, S., et al. (2020) · European Journal of Neurology · doi:10.1111/ene.14491 · Cited by 147

Covid-19: Perspectives on Innate Immune Evasion

Taefehshokr, N., Taefehshokr, S., Hemmat, N., & Heit, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.580641 · Cited by 152

COVID-19 and its cardiovascular effects: a systematic review of prevalence studies

Pellicori, P., Doolub, G., Wong, C. M., Lee, K. S., Mangion, K., Ahmad, M., Berry, C., Squire, I. B., Lambiase, P. D., Lyon, A. R., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013879 · Cited by 151

The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

Deftereos, S. G., Siasos, G., Γιαννόπουλος, Γ., Vrachatis, D. A., Angelidis, C., Giotaki, S. G., Gargalianos, P., Giamarellou, H., Gogos, C., Daikos, G. L., et al. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.03.002 · Cited by 145

Hepatic involvement in COVID‐19 patients: Pathology, pathogenesis, and clinical implications

Li, Y., & Xiao, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25973 · Cited by 146

Factors associated with the duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study

Qi, L., Yang, Y., Jiang, D., Tu, C., Wan, L., Chen, X., & Li, Z. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.045 · Cited by 145

Risk Factors for Hospitalization and Mortality due to COVID-19 in Espírito Santo State, Brazil

Soares, R. D. C. M., Mattos, L. R., & Raposo, L. M. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0483 · Cited by 144

Is there a smoker’s paradox in COVID-19?

Usman, M., Siddiqi, T. J., Khan, M. S., Patel, U. K., Shahid, I., Ahmed, J., Kalra, A., & Michos, E. D. (2020) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111492 · Cited by 145

Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China

Ma, S., Lai, X., Chen, Z., Tu, S., & Qin, K. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.068 · Cited by 144

IL-6 Inhibitors in the Treatment of Serious COVID-19: A Promising Therapy?

Atal, S., & Fatima, Z. (2020) · Pharmaceutical Medicine · doi:10.1007/s40290-020-00342-z · Cited by 150

Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology

Khera, A., Baum, S. J., Gluckman, T. J., Gulati, M., Martin, S. S., Michos, E. D., Navar, A. M., Taub, P. R., Toth, P. P., Virani, S. S., et al. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100009 · Cited by 143

Morphological anomalies of circulating blood cells in COVID ‐19

Zini, G., Bellesi, S., Ramundo, F., & d’Onofrio, G. (2020) · American Journal of Hematology · doi:10.1002/ajh.25824 · Cited by 143

COVID-19 screening using breath-borne volatile organic compounds

Chen, H., Xiao, Q., Zhang, L., Li, X., Ma, J., Zhang, C., Feng, H., & Yao, M. (2021) · Journal of Breath Research · doi:10.1088/1752-7163/ac2e57 · Cited by 142

Plasmapheresis treatment in COVID-19–related autoimmune meningoencephalitis: Case series

Doğan, L., Kaya, D., Sarıkaya, Z. T., Zengin, R., Di̇nçer, A., Akıncı, İ. Ö., & Afşar, N. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.022 · Cited by 142

Predicting COVID-19 mortality with electronic medical records

Estiri, H., Strasser, Z. H., Klann, J. G., Naseri, P., Wagholikar, K. B., & Murphy, S. N. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00383-x · Cited by 142

Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure

Abplanalp, W. T., Mas‐Peiró, S., Cremer, S., John, D., Dimmeler, S., & Zeiher, A. M. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.2468 · Cited by 147

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis

The Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent, C., Windecker, S., Andreini, D., Arbelo, E., Barbato, E., Bartorelli, A. L., Baumbach, A., Behr, E. R., Berti, S. L., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab696 · Cited by 147

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 144

The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 148

Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics

Ritter, A., Kreis, N., Louwen, F., & Yuan, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165793 · Cited by 145

Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia

Trujillo, C. H. S. (2020) · Infectio · doi:10.22354/in.v24i3.851 · Cited by 150

Machine-Learning Approaches in COVID-19 Survival Analysis and Discharge-Time Likelihood Prediction Using Clinical Data

Nemati, M., Ansary, J., & Nemati, N. (2020) · Patterns · doi:10.1016/j.patter.2020.100074 · Cited by 139

Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis

Khan, M. M. A., Khan, M. N., Mustagir, M. G., Rana, J., Islam, M. S., & Kabir, M. I. (2020) · Journal of Global Health · doi:10.7189/jogh.10.020503 · Cited by 144

Evaluation and improvement of the National Early Warning Score (NEWS2) for COVID-19: a multi-hospital study

Carr, E., Bendayan, R., Bean, D. M., Stammers, M., Wang, W., Zhang, H., Searle, T., Kraljević, Ž., Shek, A., Phan, H. T. T., et al. (2021) · BMC Medicine · doi:10.1186/s12916-020-01893-3 · Cited by 139

Application of metal-organic frameworks for sensing of VOCs and other volatile biomarkers

Hajivand, P., Jansen, J. C., Pardo, E., Armentano, D., Mastropietro, T. F., & Azadmehr, A. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215558 · Cited by 146

SARS-CoV-2 and COVID-19: From the Bench to the Bedside

Romagnoli, S., Peris, A., Gaudio, A. R. D., & Geppetti, P. (2020) · Physiological Reviews · doi:10.1152/physrev.00020.2020 · Cited by 141

Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial

Lópes, R. D., Macedo, A. V. S., Silva, P. G. M. D. B. E., Moll-Bernardes, R. J., Feldman, A., Arruda, G., de Souza, A. S., de Albuquerque, D. C., Barbosa, L. M., Santos, M. F., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.05.002 · Cited by 138

Intensive Care Unit-Acquired Weakness: Not Just Another Muscle Atrophying Condition

Lad, H., Saumur, T. M., Herridge, M. S., dos Santos, C. C., Mathur, S., Batt, J. A. E., & Gilbert, P. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217840 · Cited by 150

C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19

Sharifpour, M., Rangaraju, S., Liu, M., Alabyad, D., Nahab, F. B., Creel-Bulos, C., & Jabaley, C. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242400 · Cited by 137

Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications

Santos, A., Magro, D. O., Poderoso, R. E., & Saad, M. J. A. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00639-2 · Cited by 143

COVID-19 and the role of cytokines in this disease

Hasanvand, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00992-2 · Cited by 138

Two Years into the COVID-19 Pandemic: Lessons Learned

da Silva, S. J. R., do Nascimento, J. C. F., Mendes, R. P. G., Guarines, K. M., da Silva, C. T. A., da Silva, P. G., de Magalhães, J. J. F., Vigar, J. R. J., Silva‐Júnior, A., Kohl, A., et al. (2022) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00204 · Cited by 155

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Morales, D. R., Conover, M. M., You, S. C., Pratt, N. L., Kostka, K., Duarte‐Salles, T., Fernández‐Bertolín, S., Aragón, M., DuVall, S. L., Lynch, K. E., et al. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30289-2 · Cited by 138

Relative Lymphocytosis in COVID-19—A Ray of Hope

Ish, P., Malhotra, N., Agrawal, S. P., & Gupta, N. (2020) · Advances in respiratory medicine · doi:10.5603/arm.a2020.0098 · Cited by 11

15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study

Wang, K., Zhang, Z., Yu, M., Tao, Y., & Xie, M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06047-w · Cited by 87

Short Term Outcomes and Risk Factors for Mortality in Patients with COVID-19 in Wuhan, China: A Retrospective StudyPreprint

Zhang, S., Guo, M., Duan, L., Wu, F., Wang, Z., Xu, J., Ma, Y., Lv, Z., Tan, X., Zhang, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3551390 · Cited by 8

“Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.” Rong-Hui Du, Li-Rong Liang, Cheng-Qing Yang, Wen Wang, Tan-Ze Cao, Ming Li, Guang-Yun Guo, Juan Du, Chun-Lan Zheng, Qi Zhu, Ming Hu, Xu-Yan Li, Peng Peng and Huan-Zhong Shi. Eur Respir J 2020; 55: 2000524.

European Respiratory Society (2020) · European Respiratory Journal · doi:10.1183/13993003.50524-2020 · Cited by 18

Clinical prediction model for mortality of adult diabetes inpatients with COVID-19 in Wuhan, China: A retrospective pilot study

Su, M., Yuan, J., Peng, J., Wu, M., Yang, Y., & Peng, Y. (2020) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2020.109927 · Cited by 5